$4.50
-0.22-4.66%
Pre-Market: 5:15 PM EDT
Comments
Loading...
Cingulate (CING) Forecast
NewsEarningsCingulate (CING) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCingulate (NASDAQ:CING) Stock Quotes, Forecast and News Summary
Cingulate Stock (NASDAQ: CING) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cingulate (CING) stock?
You can purchase shares of Cingulate (NASDAQ:CING) through any online brokerage.
Who are Cingulate (CING) competitors?
Other companies in Cingulate’s space includes: Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), Addex Therapeutics (NASDAQ:ADXN), Kiora Pharmaceuticals (NASDAQ:KPRX) and Jaguar Health (NASDAQ:JAGX).
What is the forecast, or price target, for Cingulate (CING) stock?
Cingulate has a consensus price target of $10.00.
What is the current price for Cingulate (CING)?
The stock price for Cingulate (NASDAQ: CING) is $4.5 last updated January 15, 2025 at 5:15 PM EST.
Does Cingulate (CING) pay a dividend?
There are no upcoming dividends for Cingulate.
When is Cingulate (NASDAQ:CING) reporting earnings?
Cingulate’s Q4 earnings are confirmed for Monday, March 31, 2025.
Is Cingulate (CING) going to split?
There is no upcoming split for Cingulate.
What sector and industry does Cingulate (CING) operate in?
Cingulate is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.